There’s an ongoing push to improve health care affordability and reduce out-of-pocket costs, especially for prescription ...

Eli Lilly's innovative culture and strong financial commitment to developing the next generation of drugs set the company apart from its peers and fuel its long-term growth. Lilly holds ...

Adjusted EBITDA margin increased to 37.2% from 25.2% in Q4 2024, driven by cost reductions and operational improvements. Management's tone shifted positively, highlighting stronger-than-expected ...

“Insulin used to cost around $500 for one box, and now it’s down to somewhere around $150, $200, so they’ve really dropped ...